| RS121912420 |
SERPIND1
|
Health Risk |
Pathogenic |
Heparin cofactor II deficiency, Heparin cofactor II deficiency |
| RS121912421 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS121912422 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Symmetrical dyschromatosis of extremities |
| RS121912423 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Symmetrical dyschromatosis of extremities |
| RS121912424 |
CD79B
|
Health Risk |
Pathogenic |
Agammaglobulinemia 6, autosomal recessive |
| RS121912425 |
ITPR1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 15/16, Spinocerebellar ataxia type 15/16 |
| RS121912430 |
IGF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor type 1 deficiency, Growth delay due to insulin-like growth factor type 1 deficiency |
| RS121912431 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Motor neuron disease |
| RS121912432 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912433 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Spastic tetraplegia and axial hypotonia |
| RS121912434 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912435 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 10 |
| RS121912436 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS121912437 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912438 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912439 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Motor neuron disease |
| RS121912440 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS121912441 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Motor neuron disease |
| RS121912442 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS121912443 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis |
| RS121912444 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912445 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis 1, autosomal recessive |
| RS121912446 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS121912447 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912448 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912449 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912450 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912451 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912452 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912453 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912454 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912455 |
SCAF4;SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912456 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912457 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912458 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS121912459 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis 1, autosomal recessive |
| RS121912461 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS121912462 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS121912463 |
ITGB4
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS121912464 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS121912465 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS121912466 |
ITGB4
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 5A |
| RS121912467 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa |
| RS121912468 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa |
| RS121912469 |
IRF1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS121912470 |
IRF1
|
Health Risk |
Pathogenic |
Non-small cell lung carcinoma, Non-small cell lung carcinoma |
| RS121912472 |
JAK2
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121912474 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 2B, generalized intermediate |
| RS121912475 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex 2B |
| RS121912476 |
KRT5
|
Health Risk |
risk factor |
Epidermolysis bullosa simplex 2C, localized |
| RS121912478 |
KRT17
|
Health Risk |
Pathogenic/Likely pathogenic |
Pachyonychia congenita 2, Steatocystoma multiplex |
| RS121912482 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS121912483 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS121912484 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS121912485 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS121912486 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS121912487 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS121912488 |
LAMB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS121912489 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS121912490 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, Pierson syndrome |
| RS121912491 |
LAMB2
|
Health Risk |
Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS121912492 |
LAMB2
|
Health Risk |
Pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS121912493 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mandibuloacral dysplasia with type A lipodystrophy, atypical |
| RS121912494 |
LMNA
|
Health Risk |
Likely pathogenic |
Mandibuloacral dysplasia with type A lipodystrophy, Charcot-Marie-Tooth disease type 2 |
| RS121912495 |
LMNA
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to LMNA mutation, Congenital muscular dystrophy due to LMNA mutation |
| RS121912496 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital muscular dystrophy due to LMNA mutation, Charcot-Marie-Tooth disease type 2 |
| RS121912498 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS121912499 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS121912501 |
LIFR
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS121912502 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Hyperlipidemia due to hepatic triglyceride lipase deficiency |
| RS121912503 |
LPA
|
Health Risk |
Pathogenic |
Lipoprotein(a) deficiency, congenital |
| RS121912504 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912505 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912506 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912507 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912508 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912509 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome |
| RS121912510 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912511 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912512 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912513 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS121912514 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 1/2, digenic |
| RS121912515 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 2/3, digenic |
| RS121912516 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS121912517 |
LHB
|
Health Risk |
Pathogenic |
Isolated lutropin deficiency, Isolated lutropin deficiency |
| RS121912518 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Gonadotropin-independent familial sexual precocity, Precocious puberty in males |
| RS121912519 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912520 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell agenesis, Luteinizing hormone resistance |
| RS121912521 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912523 |
LHCGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Leydig cell agenesis, Gonadotropin-independent familial sexual precocity |
| RS121912524 |
LHCGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Leydig cell agenesis, Luteinizing hormone resistance |
| RS121912525 |
LHCGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Leydig hypoplasia, type I |
| RS121912526 |
LHCGR
|
Health Risk |
Likely pathogenic |
Gonadotropin-independent familial sexual precocity, Precocious puberty in males |
| RS121912527 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell hypoplasia, type II |
| RS121912528 |
LHCGR
|
Health Risk |
Likely pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912529 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell agenesis, Luteinizing hormone resistance |
| RS121912530 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell hypoplasia, type II |
| RS121912531 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, LHCGR-related disorder |
| RS121912532 |
LHCGR
|
Health Risk |
Likely pathogenic |
Leydig cell adenoma, somatic |
| RS121912533 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |